CETRAXAL EAR DROPS SOLUTION 2MG/ML
Product details
Registration number: SIN14596P
Classification: Prescription Only
Active ingredients: Ciprofloxacin Hydrochloride 2.33mg eqv Ciprofloxacin
Strength: 2mg
Dosage form: SOLUTION
Route: AURICULAR (OTIC)
Registrant: HYPHENS PHARMA PTE. LTD.
ATC code: S02AA15
HSA approval date: 29 August 2014
Manufacturer(s): Laboratorios Salvat S.A.
Manufacturing country/countries: SPAIN
What are the HSA registration number and classification for CETRAXAL EAR DROPS SOLUTION 2MG/ML?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN14596P
Classification: Prescription Only
What active ingredients and strength are recorded for CETRAXAL EAR DROPS SOLUTION 2MG/ML?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Ciprofloxacin Hydrochloride 2.33mg eqv Ciprofloxacin
Strength: 2mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for CETRAXAL EAR DROPS SOLUTION 2MG/ML?
According to the HSA dataset updated 7 August 2026:
Dosage form: SOLUTION
Route: AURICULAR (OTIC)
Who is the recorded registrant for CETRAXAL EAR DROPS SOLUTION 2MG/ML?
According to the HSA dataset updated 7 August 2026:
Registrant: HYPHENS PHARMA PTE. LTD.
Which manufacturers and countries are listed for CETRAXAL EAR DROPS SOLUTION 2MG/ML?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Laboratorios Salvat S.A.
Manufacturing country/countries: SPAIN
Where can I look up CETRAXAL EAR DROPS SOLUTION 2MG/ML in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN14596P or the exact product name CETRAXAL EAR DROPS SOLUTION 2MG/ML. The general register link does not preselect this product.
What are the source dates for this CETRAXAL EAR DROPS SOLUTION 2MG/ML record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this CETRAXAL EAR DROPS SOLUTION 2MG/ML record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN14596P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)